A detailed history of Caption Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Caption Management, LLC holds 50,000 shares of VRTX stock, worth $23.1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$23.1 Million
% of portfolio
0.41%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $1.42 Million - $1.55 Million
3,480 New
3,480 $1.45 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $11.4 Million - $14.1 Million
-48,358 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $9.29 Million - $10.9 Million
41,958 Added 655.59%
48,358 $12.6 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $601,834 - $759,730
-3,400 Reduced 34.69%
6,400 $1.41 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $1.78 Million - $1.99 Million
9,800 New
9,800 $1.78 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.